Two documents recently published by the European Commission both highlight the role off-patent drugs could have in improving healthcare access in the EU, said industry body Medicines for Europe.
The 2022 Health at a Glance Report examined the key challenges involved in developing a stronger, more resilient healthcare system following the acute phase of the COVID-19 pandemic